BOLT.TA TLV
BioLight Life Sciences Ltd.
1W: +4.6%
1M: -6.5%
3M: -25.6%
YTD: -18.1%
1Y: -46.4%
3Y: -57.5%
5Y: -57.0%
₪290.10 ($0.95)
-6.30 (-2.13%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$11M
+1.3% ▲
Capital Expenditures
$5K
+82.1% ▲
5Y CAGR: -70.1%
Free Cash Flow
-$11M
+1.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$6M
-229.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $382K | -$9M | -$26M | -$8M | -$12M |
| Depreciation & Amort. | $532K | $588K | $574K | $595K | $544K |
| Stock-Based Comp. | $332K | $315K | $54K | $382K | $0 |
| Change in Working Capital | -$1M | -$58K | $306K | -$1M | -$32K |
| Other Non-Cash Items | $148K | -$450K | $16M | -$2M | $361K |
| Operating Cash Flow | -$10M | -$10M | -$10M | -$11M | -$11M |
| — Investing Activities — | |||||
| Capital Expenditures | -$626K | -$98K | -$1M | -$28K | -$5K |
| Acquisitions (Net) | -$1M | -$2M | $0 | $8M | $0 |
| Investment Purchases | -$5M | -$9M | $0 | -$2M | -$16M |
| Investment Sales | $20M | $0 | $0 | $250K | $0 |
| Other Investing | $439K | $119K | -$537K | $1M | $163K |
| Investing Cash Flow | $13M | -$11M | -$2M | $8M | -$16M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$508K | -$551K | -$604K | -$596K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $22K | $66K | $0 | $8M | -$605K |
| Financing Cash Flow | $915K | -$485K | $3M | $8M | $21M |
| Net Change in Cash | $3M | -$20M | -$8M | $4M | -$6M |
| Cash End of Period | $33M | $13M | $5M | $10M | $4M |
| Free Cash Flow | -$11M | -$10M | -$11M | -$11M | -$11M |